Associated Papers
48-Year clinical experience and genetic analysis of pediatric primary hyperparathyroidism from a single center in China.
Chen Y et al.
Journal of Endocrinological Investigation, 2025
Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing.
Zheng Q et al.
Cancer Cell International, 2025
Multiple central giant cell granuloma of the jaws: diagnostic signposts of Noonan syndrome and RASopathy.
Friedrich RE et al.
Oral and Maxillofacial Surgery, 2024
Combination approach for CDC73-related parathyroid carcinoma in an adolescent female patient: a case report and literature review.
Kim E et al.
Therapeutic Advances in Medical Oncology, 2024
Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Chen Y et al.
Frontiers in Endocrinology, 2023
The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y et al.
International Journal of Cancer, 2020
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L et al.
Human Mutation, 2017
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors.
Katigbak A et al.
Scientific Reports, 2016
Update on parathyroid carcinoma.
Cetani F et al.
Journal of Endocrinological Investigation, 2016
Somatic HRPT2 Mutation (Arg234X) of Parathyroid Carcinoma Associated with Slipped Capital Femoral Epiphysis: A First Case Report.
Niramitmahapanya S et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 2016
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
Bricaire L et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
Cetani F et al.
Endocrine Connections, 2013
CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
Frank-Raue K et al.
European Journal of Endocrinology, 2011
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ et al.
Human Mutation, 2010
The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA et al.
The Journal of Endocrinology, 2009
HRPT2 gene analysis and the diagnosis of parathyroid carcinoma.
Cetani F et al.
Expert Review of Endocrinology & Metabolism, 2008
Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes.
Marsh DJ et al.
Expert Opinion on Medical Diagnostics, 2007
[Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
Raue F et al.
Deutsche Medizinische Wochenschrift (1946), 2007
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Cetani F et al.
European Journal of Endocrinology, 2007
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
Howell VM et al.
The Journal of Molecular Diagnostics : Jmd, 2006
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ et al.
Clinical Endocrinology, 2006
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
Cetani F et al.
The Journal of Clinical Endocrinology and Metabolism, 2004
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
Shattuck TM et al.
The New England Journal of Medicine, 2003